Cite
Ribback S, Winter S, Klatte T, et al. Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC. World J Urol. 2021;doi: 10.1007/s00345-021-03900-5.
Ribback, S., Winter, S., Klatte, T., Schaeffeler, E., Gellert, M., Stühler, V., Scharpf, M., Bedke, J., Burchardt, M., Schwab, M., Lillig, C. H., & Kroeger, N. (2021). Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC. World journal of urology, . https://doi.org/10.1007/s00345-021-03900-5
Ribback, Silvia, et al. "Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC." World journal of urology vol. (2021). doi: https://doi.org/10.1007/s00345-021-03900-5
Ribback S, Winter S, Klatte T, Schaeffeler E, Gellert M, Stühler V, Scharpf M, Bedke J, Burchardt M, Schwab M, Lillig CH, Kroeger N. Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC. World J Urol. 2021 Dec 02; doi: 10.1007/s00345-021-03900-5. Epub 2021 Dec 02. PMID: 34859284.
Copy
Download .nbib